Indication

Isovaleric acidemia

Isovaleric acidemia is a rare autosomal recessive organic acid disorder caused by a deficiency of the mitochondrial enzyme isovaleryl-CoA dehydrogenase, which impairs the normal catabolism of the branched-chain amino acid leucine. Read more about Isovaleric acidemia

11 drugs 11 manufacturers

Advertisement

Drugs that treat it

Common Isovaleric acidemia therapies.

Showing 10–11 of 11 drugs

Filter & compare in the drug finder →Opens the drug finder with Isovaleric acidemia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Isovaleric acidemia.

Isovaleric acidemia is a rare autosomal recessive organic acid disorder caused by a deficiency of the mitochondrial enzyme isovaleryl-CoA dehydrogenase, which impairs the normal catabolism of the branched-chain amino acid leucine.

This enzymatic defect predominantly manifests in neonates and young children, leading to toxic systemic accumulations of isovaleric acid and associated metabolites.

Pathophysiologically and clinically, the condition presents along a spectrum ranging from life-threatening neonatal metabolic crises to chronic intermittent decompensations typically provoked by infection, fasting, or increased protein intake.

Hallmark features include severe metabolic acidosis, hyperammonemia, vomiting, lethargy, encephalopathy, and a distinctive odor resembling sweaty feet during acute decompensation episodes.

Personalize your experience

Follow Isovaleric acidemia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it